Concepedia

Author

David Brachman

Arizona Oncology

Also Known As

Brachman, David, D BRACHMAN, D Brachman, D G Brachman, D. Brachman, D. G. Brachman, D.G. Brachman, Dave Brachman, David Brachman, David G Brachman

182

Publications

12.5K

Citations

44

H-Index

75

Concepts

All Affiliations

Arizona OncologyThe University of Texas MD Anderson Cancer CenterBarrow Neurological InstituteRTOG FoundationSt. Joseph's Hospital and Medical Center
DB

About

David Brachman is an author at Arizona Oncology specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

43

3.6K

2

Health Sciences

23

28

2.6K

3

Engineering

1

1

16

4

Public Health

1

1

22

5

Social Sciences

1

1

21

David Brachman

×

77

Publications

12.3K

Citations

44

H-Index

YearCitations

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong,

New England Journal of Medicine

2014

2.7K

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

Gregory Cairncross, Meihua Wang, Edward Shaw,

Journal of Clinical Oncology

2012

1.1K

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Jan C. Buckner, Edward G. Shaw, Stephanie L. Pugh,

New England Journal of Medicine

2016

1K

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Gregory Cairncross, Brian Berkey, Edward Shaw,

Journal of Clinical Oncology

2006

724

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol

Luís Souhami, Wendy Seiferheld, David Brachman,

International Journal of Radiation Oncology*Biology*Physics

2004

560

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge,

The Lancet

2017

392

Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of <i>IDH</i>

J. Gregory Cairncross, Meihua Wang, Robert B. Jenkins,

Journal of Clinical Oncology

2014

391

Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802

Edward G. Shaw, Meihua Wang, Stephen W. Coons,

Journal of Clinical Oncology

2012

346

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

Edward G. Shaw, Brian Berkey, Stephen W. Coons,

Journal of neurosurgery

2008

322

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity

Mark E. Oppenlander, Andrew B. Wolf, Laura A. Snyder,

Journal of neurosurgery

2014

262

Page 1